Health care pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 health care pharmaceutical companies ranked by one-year price change, at +395%, ahead of Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%). Figures as of 19 Nov 2026, 22:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+395%
- Median
- +27.0%
- Combined market value
- CZK 110.4T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +395% | CZK 111B | CZK 316.37 | 3.34% up | 395% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +332% | CZK 206.3B | CZK 2,172.07 | 3.77% down | 332% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +255% | CZK 147.2B | CZK 2,170.74 | 1.91% up | 255% up | ||
| 4 | VeradermicsMANE · Health Care | +231% | CZK 116.8B | CZK 2,767.43 | 0.38% down | 231% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +168% | CZK 89.8B | CZK 655.87 | 1.24% up | 168% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +129% | CZK 163.5B | CZK 2,080.97 | 1.59% down | 129% up | ||
| 7 | TG TherapeuticsTGTX · Health Care | +117% | CZK 218.2B | CZK 1,443.45 | 1.88% down | 117% up | ||
| 8 | Dianthus TherapeuticsDNTH · Health Care | +108% | CZK 106.3B | CZK 1,887.30 | 1.01% up | 108% up | ||
| 9 | ViatrisVTRS · Health Care | +99.0% | CZK 507.1B | CZK 442.29 | 1.97% down | 99% up | ||
| 10 | Roivant SciencesROIV · Health Care | +91.1% | CZK 628B | CZK 866.78 | 0.59% up | 91% up | ||
| 11 | Amneal PharmaceuticalsAMRX · Health Care | +90.0% | CZK 165.8B | CZK 475.88 | 2.24% down | 90% up | ||
| 12 | Praxis Precision MedicinesPRAX · Health Care | +86.0% | CZK 193.3B | CZK 6,916.90 | 1.87% up | 86% up | ||
| 13 | Edgewise TherapeuticsEWTX · Health Care | +85.9% | CZK 100.3B | CZK 915.95 | 0.48% down | 86% up | ||
| 14 | Royalty PharmaRPRX · Health Care | +78.9% | CZK 866.3B | CZK 1,506.63 | 1.38% down | 79% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | +73.9% | CZK 1T | CZK 857.44 | 8.74% down | 74% up | ||
| 16 | GenmabGMAB · Health Care | +69.7% | CZK 704.4B | CZK 1,142.43 | 0.75% up | 70% up | ||
| 17 | AlkermesALKS · Health Care | +66.2% | CZK 172.7B | CZK 1,027.41 | 1.43% down | 66% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +51.3% | CZK 1.52T | CZK 476.33 | 0.66% up | 51% up | ||
| 19 | Protagonist TherapeuticsPTGX · Health Care | +51.0% | CZK 180.1B | CZK 2,759.20 | 2.47% down | 51% up | ||
| 20 | Ligand PharmaceuticalsLGND · Health Care | +50.1% | CZK 127.7B | CZK 6,383.84 | 3.94% down | 50% up | ||
| 21 | Merck & CoMRK · Health Care | +45.1% | CZK 7.28T | CZK 2,954.76 | 3.61% down | 45% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | +44.7% | CZK 103.2B | CZK 1,074.58 | 3.86% down | 45% up | ||
| 23 | Belite BioBLTE · Health Care | +43.1% | CZK 136.5B | CZK 3,359.89 | 3.33% down | 43% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +41.0% | CZK 337.7B | CZK 5,260.54 | 4.57% down | 41% up | ||
| 25 | Johnson & JohnsonJNJ · Health Care | +34.3% | CZK 14.31T | CZK 5,943.33 | 2.04% down | 34% up | ||
| 26 | Mirum PharmaceuticalsMIRM · Health Care | +33.7% | CZK 138.7B | CZK 2,124.91 | 3.27% up | 34% up | ||
| 27 | Eli LillyLLY · Health Care | +32.5% | CZK 26.78T | CZK 30,059.72 | 2.29% down | 33% up | ||
| 28 | Bristol-Myers SquibbBMY · Health Care | +29.6% | CZK 2.65T | CZK 1,297.95 | 2.05% down | 30% up | ||
| 29 | Ascendis PharmaASND · Health Care | +29.0% | CZK 373.5B | CZK 5,694.60 | 5.32% down | 29% up | ||
| 30 | Regeneron PharmaceuticalsREGN · Health Care | +28.3% | CZK 2.13T | CZK 20,542.47 | 2.35% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +27.0% | CZK 2.94T | CZK 11,583.64 | 2.94% down | 27% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | +25.7% | CZK 292.3B | CZK 584.90 | 1.54% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +24.8% | CZK 6.35T | CZK 3,364.34 | 2.57% down | 25% up | ||
| 34 | AbbVieABBV · Health Care | +24.7% | CZK 11.15T | CZK 6,308.20 | 0.86% down | 25% up | ||
| 35 | United TherapeuticsUTHR · Health Care | +21.6% | CZK 529.8B | CZK 12,438.86 | 3.16% down | 22% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +20.7% | CZK 338.8B | CZK 1,739.35 | 0.22% up | 21% up | ||
| 37 | Rhythm PharmaceuticalsRYTM · Health Care | +18.3% | CZK 180.2B | CZK 2,598.57 | 1.88% down | 18% up | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | +17.1% | CZK 264.7B | CZK 1,366.47 | 0.02% down | 17% up | ||
| 39 | BeOne MedicinesONC · Health Care | +15.5% | CZK 1.02T | CZK 8,892.53 | 0.97% down | 16% up | ||
| 40 | PfizerPFE · Health Care | +15.0% | CZK 3.49T | CZK 612.71 | 1.85% down | 15% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +13.2% | CZK 137.3B | CZK 971.13 | 1.25% up | 13% up | ||
| 42 | Dr. Reddy's LaboratoriesRDY · Health Care | +7.77% | CZK 275.1B | CZK 329.94 | 1.00% down | 8% up | ||
| 43 | GSKGSK · Health Care | +5.36% | CZK 2.13T | CZK 1,063.90 | 1.56% down | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +0.79% | CZK 6.05T | CZK 3,902.52 | 1.87% down | 1% up | ||
| 45 | GrifolsGRFS · Health Care | +0.47% | CZK 124.2B | CZK 182.43 | 3.19% down | 0% up | ||
| 46 | SanofiSNY · Health Care | -3.62% | CZK 2.46T | CZK 1,024.74 | 2.25% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -6.50% | CZK 158.8B | CZK 3,018.61 | 1.25% up | 6% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -9.67% | CZK 158.2B | CZK 1,445.68 | 4.15% down | 10% down | ||
| 49 | Abbott LaboratoriesABT · Health Care | -15.7% | CZK 4T | CZK 2,310.90 | 0.58% down | 16% down | ||
| 50 | Novo NordiskNVO · Health Care | -17.2% | CZK 3.81T | CZK 864.78 | 1.42% down | 17% down | ||
| 51 | CytokineticsCYTK · Health Care | -19.2% | CZK 159.5B | CZK 1,144.88 | 0.27% up | 19% down | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -19.9% | CZK 107.4B | CZK 617.16 | 0.25% down | 20% down | ||
| 53 | PTC TherapeuticsPTCT · Health Care | -21.2% | CZK 108.4B | CZK 1,297.61 | 3.16% down | 21% down | ||
| 54 | ZoetisZTS · Health Care | -26.2% | CZK 730.3B | CZK 1,797.42 | 5.59% down | 26% down | ||
| 55 | Madrigal PharmaceuticalsMDGL · Health Care | -26.6% | CZK 205B | CZK 8,826.67 | 0.34% down | 27% down | ||
| 56 | ABIVAXABVX · Health Care | -31.8% | CZK 157.1B | CZK 1,794.30 | 3.79% down | 32% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -36.2% | CZK 188.1B | CZK 235.16 | 0.67% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.0% | CZK 705.1B | CZK 3,213.95 | 20.58% up | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -41.0% | CZK 69.5B | CZK 358.19 | 0.92% down | 41% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -62.5% | CZK 100.9B | CZK 605.59 | 0.62% down | 63% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.5% | CZK 440.5B | CZK 3,288.70 | 1.06% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2480 CZK).
Questions and answers
Which health care pharmaceutical companies rank first by one-year price change?
Erasca (+395%), Spyre Therapeutics (+332%) and Oruka Therapeutics (+255%) are the top three of the 61 health care pharmaceutical companies ranked by one-year price change as of 19 Nov 2026, 22:14 UTC.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by one-year price change have a combined market value of CZK 110.4T as of 19 Nov 2026, 22:14 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care pharmaceutical companies by one-year price change”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.